181 related articles for article (PubMed ID: 15203329)
1. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
Anal Biochem; 2004 Jul; 330(2):242-50. PubMed ID: 15203329
[TBL] [Abstract][Full Text] [Related]
2. Lanthanide-based luminescent assays for ligand-receptor interactions.
Handl HL; Gillies RJ
Life Sci; 2005 Jun; 77(4):361-71. PubMed ID: 15894006
[TBL] [Abstract][Full Text] [Related]
3. Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.
Handl HL; Vagner J; Yamamura HI; Hruby VJ; Gillies RJ
Anal Biochem; 2005 Aug; 343(2):299-307. PubMed ID: 16004955
[TBL] [Abstract][Full Text] [Related]
4. Cell-based beta2-adrenergic receptor-ligand binding assay using synthesized europium-labeled ligands and time-resolved fluorescence.
Martikkala E; Lehmusto M; Lilja M; Rozwandowicz-Jansen A; Lunden J; Tomohiro T; Hänninen P; Petäjä-Repo U; Härmä H
Anal Biochem; 2009 Sep; 392(2):103-9. PubMed ID: 19464246
[TBL] [Abstract][Full Text] [Related]
5. Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.
De Silva CR; Vagner J; Lynch R; Gillies RJ; Hruby VJ
Anal Biochem; 2010 Mar; 398(1):15-23. PubMed ID: 19852924
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
[TBL] [Abstract][Full Text] [Related]
7. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
[TBL] [Abstract][Full Text] [Related]
8. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.
Shabanpoor F; Hughes RA; Bathgate RA; Zhang S; Scanlon DB; Lin F; Hossain MA; Separovic F; Wade JD
Bioconjug Chem; 2008 Jul; 19(7):1456-63. PubMed ID: 18529069
[TBL] [Abstract][Full Text] [Related]
10. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
Oh KS; Lee S; Lee BH
Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
[TBL] [Abstract][Full Text] [Related]
11. Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies.
Mazor O; Hillairet de Boisferon M; Lombet A; Gruaz-Guyon A; Gayer B; Skrzydelsky D; Kohen F; Forgez P; Scherz A; Rostene W; Salomon Y
Anal Biochem; 2002 Feb; 301(1):75-81. PubMed ID: 11811969
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
Alleti R; Vagner J; Dehigaspitiya DC; Moberg VE; Elshan NG; Tafreshi NK; Brabez N; Weber CS; Lynch RM; Hruby VJ; Gillies RJ; Morse DL; Mash EA
Bioorg Med Chem; 2013 Sep; 21(17):5029-38. PubMed ID: 23890524
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-based peptide screening using ligand peptides directly conjugated to a thiolated glass surface.
Lim CH; Cho HM; Choo J; Neff S; Jungbauer A; Kumada Y; Katoh S; Lee EK
Biomed Microdevices; 2009 Jun; 11(3):663-9. PubMed ID: 19142733
[TBL] [Abstract][Full Text] [Related]
14. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
15. Development of lanthanide-labeled human INSL3 as an alternative probe to radioactively labeled INSL3 for use in bioassays.
Shabanpoor F; Hughes RA; Bathgate RA; Separovic F; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():87-90. PubMed ID: 19416164
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin 4 receptors interact with antimicrobial frog peptide analogues.
Do EU; Jo EB; Choi G; Piao LZ; Shin J; Seo MD; Kang SJ; Lee BJ; Kim KH; Kim JB; Kim SI
Biochem Biophys Res Commun; 2006 May; 343(4):1094-100. PubMed ID: 16579969
[TBL] [Abstract][Full Text] [Related]
17. Europium-labeled melanin-concentrating hormone analogues: ligands for measuring binding to melanin-concentrating hormone receptors 1 and 2.
Gao X; Hsu CK; Heinz LJ; Morin J; Shi Y; Shukla NK; Smiley DL; Xu J; Zhong B; Slieker LJ
Anal Biochem; 2004 May; 328(2):187-95. PubMed ID: 15113696
[TBL] [Abstract][Full Text] [Related]
18. Kinetic evidence for tandemly arranged ligand binding sites in melanocortin 4 receptor complexes.
Kopanchuk S; Veiksina S; Mutulis F; Mutule I; Yahorava S; Mandrika I; Petrovska R; Rinken A; Wikberg JE
Neurochem Int; 2006 Oct; 49(5):533-42. PubMed ID: 16764968
[TBL] [Abstract][Full Text] [Related]
19. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
[TBL] [Abstract][Full Text] [Related]
20. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
